ArticleACS omega2025
Unraveling the Molecular Inhibition and Conformational Changes of Hsp70 and Hsc70 Induced by VER-155008, a Competitive ATPase Inhibitor through Molecular Dynamics Simulations and Principal Component Analysis.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The heat shock protein 70 kDa (Hsp70) is critical for the survival of cancer cells, playing a role in developing chemotherapy resistance, since it inhibits apoptosis of these cells and ensures their survival in stressful environments. Due to its structural similarity with heat shock cognate 70 kDa (Hsc70), the design of new selective Hsp70 inhibitors presents significant challenges. Previous studies have reported that the molecule VER-155008 functions as a nonselective inhibitor of Hsp70 by binding to the nucleotide-binding domain of both proteins, thereby acting as a competitive inhibitor of adenosine triphosphate (ATP) binding. In the present study, molecular dynamics (MD) simulations and free energy landscape (FEL) analysis were used to investigate the conformational dynamics of Hsp70 and Hsc70 with the competitive ATPase inhibitor VER-155008, revealing its binding mechanism and its role in inducing a half-open conformation that inhibits ATP binding. Our findings highlight key residues Ser275, Lys271, and Glu268 involved in the stabilization of the inhibitor binding and some conformational states in both proteins due to the inhibitor binding, explaining molecular characteristics that could be used to develop new selective inhibitors at the nucleotide binding site of Hsp70, thus aiming to advance the development of targeted therapies in cancer treatment.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.